Revenio Group Oyj (0KFH.L)
EUR 22.5
(-6.25%)
EUR 22.5
(-6.25%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 30.09 Million EUR | -7.18% |
| 2022 | 32.78 Million EUR | 23.27% |
| 2021 | 25.34 Million EUR | 18.15% |
| 2020 | 19.57 Million EUR | 67.05% |
| 2019 | 14.6 Million EUR | 24.82% |
| 2018 | 10.79 Million EUR | 3.52% |
| 2017 | 10.43 Million EUR | 33.8% |
| 2016 | 7.8 Million EUR | 20.51% |
| 2015 | 6.49 Million EUR | 23.87% |
| 2014 | 5.21 Million EUR | -15.52% |
| 2013 | 6.42 Million EUR | 11.16% |
| 2012 | 5.55 Million EUR | 28.83% |
| 2011 | 3.91 Million EUR | 61.22% |
| 2010 | 603 Thousand EUR | 476.29% |
| 2009 | 464 Thousand EUR | -91.08% |
| 2008 | 5.2 Million EUR | 0.0% |
| 2005 | 1.13 Million EUR | 701.69% |
| 2004 | -1.09 Million EUR | 15.27% |
| 2003 | -1.24 Million EUR | 76.39% |
| 2002 | -5.36 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 6.2 Million EUR | -39.53% |
| 2024 Q3 | 6.7 Million EUR | -5.63% |
| 2024 Q2 | 7.1 Million EUR | 14.52% |
| 2023 Q2 | 5.8 Million EUR | -18.31% |
| 2023 Q1 | 7.1 Million EUR | -27.94% |
| 2023 FY | - EUR | -7.18% |
| 2023 Q4 | 10.5 Million EUR | 47.89% |
| 2023 Q3 | 7.1 Million EUR | 22.41% |
| 2022 Q1 | 6.4 Million EUR | -27.62% |
| 2022 FY | - EUR | 23.27% |
| 2022 Q4 | 9.85 Million EUR | 15.92% |
| 2022 Q3 | 8.5 Million EUR | 7.59% |
| 2022 Q2 | 7.9 Million EUR | 23.44% |
| 2021 Q1 | 5.2 Million EUR | -30.25% |
| 2021 FY | - EUR | 18.15% |
| 2021 Q4 | 8.84 Million EUR | 31.97% |
| 2021 Q3 | 6.7 Million EUR | 28.85% |
| 2021 Q2 | 5.2 Million EUR | 0.0% |
| 2020 FY | - EUR | 67.05% |
| 2020 Q2 | 4.1 Million EUR | 36.67% |
| 2020 Q3 | 6.2 Million EUR | 51.22% |
| 2020 Q1 | 3 Million EUR | -47.46% |
| 2020 Q4 | 7.45 Million EUR | 20.24% |
| 2019 FY | - EUR | 24.82% |
| 2019 Q1 | 2.7 Million EUR | -15.23% |
| 2019 Q4 | 5.71 Million EUR | 26.89% |
| 2019 Q3 | 4.5 Million EUR | 246.15% |
| 2019 Q2 | 1.3 Million EUR | -51.85% |
| 2018 Q1 | 2.3 Million EUR | -32.69% |
| 2018 Q4 | 3.18 Million EUR | 22.5% |
| 2018 FY | - EUR | 3.52% |
| 2018 Q2 | 2.6 Million EUR | 13.04% |
| 2018 Q3 | 2.6 Million EUR | 0.0% |
| 2017 Q1 | 1.8 Million EUR | -27.57% |
| 2017 FY | - EUR | 33.8% |
| 2017 Q3 | 2.7 Million EUR | 8.0% |
| 2017 Q4 | 3.41 Million EUR | 26.56% |
| 2017 Q2 | 2.5 Million EUR | 38.89% |
| 2016 FY | - EUR | 20.51% |
| 2016 Q4 | 2.48 Million EUR | 24.25% |
| 2016 Q2 | 1.9 Million EUR | 26.67% |
| 2016 Q3 | 2 Million EUR | 5.26% |
| 2016 Q1 | 1.5 Million EUR | -3.91% |
| 2015 Q1 | 1.5 Million EUR | 13.98% |
| 2015 FY | - EUR | 23.87% |
| 2015 Q4 | 1.56 Million EUR | -13.28% |
| 2015 Q3 | 1.8 Million EUR | 12.5% |
| 2015 Q2 | 1.6 Million EUR | 6.67% |
| 2014 Q2 | 1.6 Million EUR | 14.29% |
| 2014 Q1 | 1.4 Million EUR | 52.67% |
| 2014 FY | - EUR | -15.52% |
| 2014 Q4 | 1.31 Million EUR | 9.67% |
| 2014 Q3 | 1.2 Million EUR | -25.0% |
| 2013 Q4 | 917 Thousand EUR | -42.69% |
| 2013 Q3 | 1.6 Million EUR | 14.29% |
| 2013 Q1 | 1.4 Million EUR | -64.59% |
| 2013 Q2 | 1.4 Million EUR | 0.0% |
| 2013 FY | - EUR | 11.16% |
| 2012 FY | - EUR | 28.83% |
| 2012 Q1 | 500 Thousand EUR | 60.77% |
| 2012 Q3 | 1.4 Million EUR | 800.0% |
| 2012 Q2 | -200 Thousand EUR | -140.0% |
| 2012 Q4 | 3.95 Million EUR | 182.43% |
| 2011 Q3 | 1.5 Million EUR | 7.14% |
| 2011 Q4 | 311 Thousand EUR | -79.27% |
| 2011 FY | - EUR | 61.22% |
| 2011 Q1 | 1.1 Million EUR | 572.1% |
| 2011 Q2 | 1.4 Million EUR | 27.27% |
| 2010 Q3 | 900 Thousand EUR | 1000.0% |
| 2010 Q1 | - EUR | -100.0% |
| 2010 FY | - EUR | 476.29% |
| 2010 Q2 | -100 Thousand EUR | 0.0% |
| 2010 Q4 | -233 Thousand EUR | -125.89% |
| 2009 Q1 | 100 Thousand EUR | 0.0% |
| 2009 Q4 | 164 Thousand EUR | -67.2% |
| 2009 FY | - EUR | -91.08% |
| 2009 Q3 | 500 Thousand EUR | 266.67% |
| 2009 Q2 | -300 Thousand EUR | -400.0% |
| 2008 FY | - EUR | 0.0% |
| 2005 FY | - EUR | 701.69% |
| 2004 FY | - EUR | 15.27% |
| 2003 FY | - EUR | 76.39% |
| 2002 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Cegedim SA | 95.25 Million EUR | 68.41% |
| Guerbet SA | 90.09 Million EUR | 66.602% |
| Nexus AG | 53.43 Million EUR | 43.684% |
| Bastide Le Confort Médical SA | 110.32 Million EUR | 72.726% |
| Drägerwerk AG & Co. KGaA | 318.33 Million EUR | 90.548% |
| Sartorius Aktiengesellschaft | 811.2 Million EUR | 96.291% |
| LNA Santé SA | 144.63 Million EUR | 79.196% |
| Siemens Healthineers AG | 4.22 Billion EUR | 99.288% |
| Medios AG | 52.81 Million EUR | 43.029% |
| Equasens Société anonyme | 71.29 Million EUR | 57.797% |
| Stratec SE | 39.82 Million EUR | 24.437% |